I am Managing Editor, US Commercial News, for the Informa Pharma Insights publications Scrip and The Pink Sheet. Views expressed here are strictly my own.

Read Full Bio →


Mandy Jackson is the US West Coast Editor for Scrip Intelligence. Her focus is US biotech and pharma, including financial, deal making and clinical trials news. Mandy has been a business news reporter for 15 years, covering biotech and pharma companies, biotech law and commercial real estate. She...

Search Tweets

Twitter Feed

@ScripMandy — 3,188 followers, 13,600 tweets

Aug 18, 2017

RT @SGottliebFDA: FDA Reauthorization Act enables @US_FDA to continue advancing patient care. We're grateful to those who made this #bipartisan law possible

Aug 18, 2017

RT @dgingery: Trump has signed #FDA user fee reauthorization. Extended fee programs begin Oct. 1.

Aug 18, 2017

RT @steveubl: The Administration & Congress deserve credit for work on the FDA Reauthorization Act of 2017 - a big win for patien…

Aug 18, 2017

Otherwise have been catching up on things. Anyway, haven't been tweeting much about stories lately, so there you go. (Sorry about paywall).

Show more